Evidence map›Paper›PMID 35429763›Full record

Trial reportComprehensive psychiatry2022

Managing the COVID-19 pandemic in people with mental disorders: An exploratory telephone interview study in a psychiatric outpatient department.

Lisa Kertzscher, Elisabeth Kohls, Sabrina Baldofski, Raiko Moeller, Georg Schomerus, Christine Rummel-Kluge

Abstract readClinical Trial
In one paragraph

Trial report in Comprehensive psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Effect of the COVID-19 Pandemic on Psychiatric Service Use Among Psychiatric Outpatients.Turk psikiyatri dergisi = Turkish journal of psychiatry · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lisa KertzscherLeipzig University, Medical Faculty, Department of Psychiatry and Psychotherapy, Semmelweisstrasse 10, Haus 13, 04103 Leipzig, Germany. Electronic address: Lisa.Kertzscher@medizin.uni-leipzig.de.
Elisabeth KohlsLeipzig University, Medical Faculty, Department of Psychiatry and Psychotherapy, Semmelweisstrasse 10, Haus 13, 04103 Leipzig, Germany; University Leipzig Medical Center, Department of Psychiatry and Psychotherapy, Semmelweisstrasse 10, Haus 13, 04103 Leipzig, Germany. Electronic address: Elisabeth.Kohls@medizin.uni-leipzig.de.
Sabrina BaldofskiLeipzig University, Medical Faculty, Department of Psychiatry and Psychotherapy, Semmelweisstrasse 10, Haus 13, 04103 Leipzig, Germany. Electronic address: Sabrina.Baldofski@medizin.uni-leipzig.de.
Raiko MoellerLeipzig University, Medical Faculty, Department of Psychiatry and Psychotherapy, Semmelweisstrasse 10, Haus 13, 04103 Leipzig, Germany.
Georg SchomerusLeipzig University, Medical Faculty, Department of Psychiatry and Psychotherapy, Semmelweisstrasse 10, Haus 13, 04103 Leipzig, Germany; University Leipzig Medical Center, Department of Psychiatry and Psychotherapy, Semmelweisstrasse 10, Haus 13, 04103 Leipzig, Germany. Electronic address: Georg.Schomerus@medizin.uni-leipzig.de.
Christine Rummel-KlugeLeipzig University, Medical Faculty, Department of Psychiatry and Psychotherapy, Semmelweisstrasse 10, Haus 13, 04103 Leipzig, Germany; University Leipzig Medical Center, Department of Psychiatry and Psychotherapy, Semmelweisstrasse 10, Haus 13, 04103 Leipzig, Germany. Electronic address: Christine.Rummel-Kluge@medizin.uni-leipzig.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic and associated lockdown measures reduced well-being in the general population significantly and led to an increase in anxiety and depression symptoms, however, results on the impact on people with mental disorders are heterogeneous to date. The aim of this study was to investigate the mental health status, social support, perceived stress, and the medical care provision of people with mental disorders during the time period immediately after the first COVID-19 lockdown in spring 2020 in Germany.

methodsParticipants were people with mental disorders currently receiving treatment in the psychiatric outpatient department of the University Hospital Leipzig, Germany. Structured telephone interviews were administered to assess depressive symptoms, self-rated medical care provision, attitudes and social and emotional aspects of the pandemic (social support, perceived stress, loneliness, resilience, and agreeableness).

resultsA total of N = 106 people completed the telephone interview. The most frequent clinician-rated diagnoses were attention deficit disorder/attention deficit hyperactivity disorder (ADD/ADHD; n = 29, 27.4%) and obsessive-compulsive disorder (OCD; n = 24, 22.6%). The mean Patient Health Questionnaire-9 sum score was 10.91 (SD = 5.71) and the majority of participants (n = 56, 52.8%) reported clinically relevant depressive symptoms. A low self-rated medical care provision was significantly associated with higher depressive symptom load. In a regression analysis, higher perceived stress levels and low medical care provision significantly predicted depressive symptoms. Furthermore, 38.1% (n = 40) reported to feel relieved as a result of the restrictions and, due to previous experience in dealing with crisis, half of the participants (n = 53, 50.5%) stated they were better able to deal with the current situation than the general population.

conclusionsThis study emphasizes the importance of maintenance of medical care provision for people with mental disorders, as cancelled or postponed treatment appointments and perceived stress were associated with higher depressive symptoms. Regular treatment services showed to have a protective effect. In addition, a majority of people with mental disorders felt prepared for managing the COVID pandemic due to existing crisis management abilities. These resources should also be taken into account for further future treatment considerations.

trial registrationGerman Clinical Trials Register (DRKS00022071).

Indexed as

COVID-19Obsessive-Compulsive DisorderCommunicable Disease ControlHumansOutpatientsPandemicsQualitative ResearchTelephoneCOVID-19 lockdownDepressive symptomsMedical care provisionMental disorderPandemic (COVID-19)Psychiatry

Identifiers

PMID35429763
PMCPMC8993418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.